PAPER Menon J, Kantipudi SJ, Vinoth S, Kuchipudi JD
SEARCH RESULTS
1792 RESULTS
PAPER Pardo K, Khasminsky V, Keret O, Benninger F, Goldberg I, Shelef I, Auriel E, Glik A
Alzheimer's disease patients have smaller venous drainage system compared to cognitively healthy controls.
Alzheimers Dement. 2025 Feb;21(2):e14551. Epub 2025 Feb 12 PubMed.PAPER Ding N, Song Y, Zhang Y, Yu W, Li X, Li W, Li L
Heat-shock chaperone HSPB1 mitigates poly-glycine-induced neurodegeneration via restoration of autophagic flux.
Autophagy. 2025 Feb 25;:1-18. Epub 2025 Feb 25 PubMed.PAPER Duggan MR, Paterson C, Lu Y, Biegel H, Dark HE, Cordon J, Bilgel M, Kaneko N, Shibayama M, Kato S, Furuichi M, Waga I, Hiraga K, Katsuno M, Nishita Y, Otsuka R, Davatzikos C, Erus G, Loupy K, Simpson M, Lewis A, Moghekar A, Palta P, Gottesman RF, Resnick SM, Coresh J, Williams SA, Walker KA
The Dementia SomaSignal Test (dSST): A plasma proteomic predictor of 20-year dementia risk.
Alzheimers Dement. 2025 Feb;21(2):e14549. Epub 2025 Feb 12 PubMed.PAPER Aqil A, Yasmeen I, Parveen I, Nadaf A, Jiba U, Adil M, Hasan N, Kesharwani P, Ahmad FJ
WITHDRAWN: In-Depth Analysis of Mangiferin and Its Formulations for Alleviating Neurodegenerative Diseases: A Comprehensive Review.
Eur J Pharmacol. 2025 Feb 10;:177354. Epub 2025 Feb 10 PubMed.PAPER Ratne N, Jari S, Tadas M, Katariya R, Kale M, Kotagale N, Madia D, Umekar M, Taksande B
Neurobiological role and therapeutic potential of exercise-induced irisin in Alzheimer's disease management.
Ageing Res Rev. 2025 Mar;105:102687. Epub 2025 Feb 10 PubMed.PAPER Acharya M, Deo RC, Barua PD, Devi A, Tao X
EEGConvNeXt: A novel convolutional neural network model for automated detection of Alzheimer's Disease and Frontotemporal Dementia using EEG signals.
Comput Methods Programs Biomed. 2025 Apr;262:108652. Epub 2025 Feb 8 PubMed.PAPER Singh P, Kadam NY, Panigrahi R, Mehrotra A, Upadhayay K, Dey M, Tyagi A, Aquib M, Nielsen J, Kleijwegt G, Singh P, Sharma A, Rao A, Otzen DE, Kumar A, Sharma D
Sulfamerazine as a Potential Modulator against α-Synuclein Aggregation and Associated Toxicity.
ACS Chem Neurosci. 2025 Mar 5;16(5):880-894. Epub 2025 Feb 12 PubMed.PAPER Lonkar N, Latz E, McManus RM
Neuroinflammation and immunometabolism in neurodegenerative diseases.
Curr Opin Neurol. 2025 Apr 1;38(2):163-171. Epub 2025 Feb 12 PubMed.PAPER Zhu Y, Tian M, Lu S, Qin Y, Zhao T, Shi H, Li Z, Qin D
The antioxidant role of aromatic plant extracts in managing neurodegenerative diseases: A comprehensive review.
Brain Res Bull. 2025 Mar;222:111253. Epub 2025 Feb 10 PubMed.PAPER Krinsky-McHale SJ, Kovacs CM, Lee JH, Listwan TA, Pang DI, Schupf N, Tycko B, Zigman WB, Silverman W
Validity of one-time assessments for identifying prodromal Alzheimer's disease in adults with Down syndrome.
Alzheimers Dement (Amst). 2025;17(1):e70076. Epub 2025 Feb 11 PubMed.PAPER García-Alba J, Molanes-López EM, Zuluaga P, Bell-Fenellos C, Vaquero L, Alfayate E, García F, Mateo G, Modenhauer F, Galván-Román JM, Bajo R, Fernández A
Cognitive markers for the distinction between asymptomatic and prodromal Alzheimer's disease in Down syndrome: Correlations with volumetric brain changes.
Alzheimers Dement (Amst). 2025;17(1):e70084. Epub 2025 Feb 11 PubMed.Laykea Tafesse
Merck, United States
SORL1 c.3050-2179G> A
MUTATIONS SORL1 121564761 GRCh38/hg38 rs9665907 G A 121435470 GRCh37/hg19 rs9665907 G A Intron 21 Non-Coding c.3050-2179G>A Alzheimer's Disease This variant is one of 31 intronic variants in SORL1 that compose a haplotype associated with a reduced risk of A
SORL1 c.3050-2062T> C
MUTATIONS SORL1 121564878 GRCh38/hg38 rs11218343 T C 121435587 GRCh37/hg19 rs11218343 T C Intron 21 Non-Coding c.3050-2062T>C Alzheimer's Disease This variant is one of 31 intronic variants in SORL1 that compose a haplotype associated with a reduced risk of
Current Filters
- Date Range : Feb 2025 to Mar 2025 x